Rare diseases
Investigational molecules
Locations
201 Brookline Avenue Suite 1101, 02215-4153, United States
Chronic Hepatitis B is the central therapeutic area in the sponsor’s clinical research activity, with interest focused on antiviral treatment and disease control in a persistent liver infection.
The sponsor’s research activity in this area aligns with the development of therapies aimed at managing viral persistence and improving outcomes in chronic viral hepatitis.
Nchroma Bio Inc. runs clinical trials in conditions such as Chronic hepatitis B, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
FranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
